Friday, March 20, 2015 9:56:30 AM
DUKE BASKETBALL and NOTRE DAME FOOTBALL
Recent PRTA News
- Prothena to Participate in Upcoming Healthcare Conferences • Business Wire • 08/29/2024 08:05:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/08/2024 09:13:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 08:14:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 08:09:02 PM
- Prothena Reports Second Quarter 2024 Financial Results and Business Highlights • Business Wire • 08/08/2024 08:05:00 PM
- Prothena to Report Second Quarter 2024 Financial Results on August 8 • Business Wire • 08/01/2024 08:05:00 PM
- Prothena Announces Bristol Myers Squibb Opt-in for Exclusive Global License for PRX019, the Second Program from Global Neuroscience Research and Development Collaboration • Business Wire • 05/28/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 08:42:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 08:37:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 08:29:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/17/2024 08:08:55 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/08/2024 08:19:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2024 08:09:01 PM
- Prothena Reports First Quarter 2024 Financial Results and Business Highlights • Business Wire • 05/08/2024 08:05:00 PM
- Prothena to Report First Quarter 2024 Financial Results on May 8 • Business Wire • 05/01/2024 08:05:00 PM
- Prothena Announces Review on Birtamimab Mechanism of Action and Pharmacological Characteristics Published in Leukemia & Lymphoma • Business Wire • 04/15/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 02:03:16 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 02:01:40 AM
- Prothena to Participate in Upcoming Healthcare Conferences • Business Wire • 03/05/2024 09:05:00 PM
- Prothena Appoints David Ford to Newly Created Chief People Officer Position • Business Wire • 03/04/2024 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/01/2024 02:11:54 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/01/2024 02:09:37 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/01/2024 02:08:29 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/01/2024 02:06:06 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/01/2024 02:03:58 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM